CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

Understanding the TB Cohort Review Process: Instruction Guide 2006

Return Table of Contents

What Is the Cohort Review Method?

3.  Timeline for Activities in the Cohort Review Process

A “cohort” is a group of TB patients who are being managed over a specific period of time, usually 3 months.  In order to evaluate treatment and contact investigation outcomes, the patients’ cases are reviewed approximately 6–9 months after initial case reporting.  This is after most patients with TB disease have had time to complete treatment and after most contacts have been identified, evaluated, and started on treatment for latent TB infection (LTBI), if indicated.  A review at 6–9 months allows the TB control team to evaluate the adequacy of treatment and correct any problem areas while there is still time for the patient to complete treatment within 365 days.  Most contacts infected with LTBI will not have completed therapy because of the time gap between patient reporting, testing of contacts, and the 9-month duration of standard isoniazid (INH) treatment.  Contacts on treatment for LTBI should be tracked through to completion by the case manager.  The data analyst reports treatment completion rate for contacts at the next review session.

The following timeline illustrates the cohort review process:

Table 8:  Cohort Review Timeline
1ST Quarter Months 1–3 2ND Quarter Months 4–6 3RD Quarter Months 7–9 4TH Quarter Months 10–12 Next Year 1ST Quarter Months 1–3
TB cases counted

Treatment started

Contact investigation initiated

Ongoing treatment of patients with TB disease

Contacts evaluated and started on treatment, as necessary

Ongoing treatment of patients with TB disease

Contacts evaluated and started on treatment, as necessary

TB disease treatment completed

Infected contacts continue on treatment for LTBI

Contacts identified in previous year’s 1st quarter complete treatment
Cohort review process begins, ongoing case management, case review meetings, cohort review practice session Cohort Review Session

Begin to follow up on suggestions from cohort review

Treatment completion rate presented for contacts of cases from previous 1st quarter

Continue to follow up on suggestions made during cohort review session

This cycle is repeated throughout the year.  Cohort review sessions take place each quarter so that every TB case and contact investigation receives a thorough review.  An example of a cohort review schedule is presented below.

Table 9:  Example of a Cohort Review Schedule
Quarter Case Reported Quarter Case Reviewed
1st  (Jan-Mar 05) 4th  (Oct-Dec 05)
2nd  (Apr-Jun 05) 1st  (Jan-Mar 06)
3rd  (Jul-Sep 05) 2nd  (Apr-Jun 06)
4th  (Oct-Dec 05) 3rd  (Jul-Sep 06)

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov